Case Report

The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report


Chronic granulomatous disease (CGD) described as an essential immunodeficiency problem of phagocytic cells resulting in a phagocyte dysfunction and inability to kill a spectrum of bacteria and fungi. Despite the fact that CGD patients are more susceptible to intracellular infections, visceral leishmaniasis has been reported rarely in these cases. Here, we report an uncommon case of visceral leishmaniasis in a child with CGD. An 8-yr old boy with CGD presented to the infectious disease ward, Children's Medical Center, Tehran University of Medical Sciences, Iran after the onset of 20 days fever with chronic crusted ulcer approximately 3 cm × 3cm on the left upper limb and a small ulcer measuring 0.5 cm × 0.5 cm on the right knee with moderate secretion. Bone Marrow Aspiration (BMA) and Bone Marrow Biopsies (BMB) of fragmented samples were performed and polymorphic population of hematopoietic cells, Megakaryocytes and Leishman bodies were seen. The patient was treated with meglumine antimoniate (Glucantime®) 20 mg/kg for 28 days and after partial improvement patient discharged and continue the treatment at home. Amphotericin B lipid complex (Ambisome®) (3–5 mg/kg per dose once) was administered every 3 -4 weeks for 18 months as secondary prophylaxis that was well tolerated and effective.

1. Soler-Palacin P, Margareto C, Llobet P, et al. Chron-ic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr). 2007;35(3):83-9.
2. Seger RA. Modern management of chronicgranu-lomatous disease. Br J Haematol. 2008;140(3):255-66.
3. Seger R. Chronic granulomatous disease: recent advances in pathophysiology and treatment. Neth J Med. 2010;68(11):334-40.
4. Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol. 2010;38(1):3-10.
5. Martín A, Marques L, Soler-Palacín P, et al. Visceral leishmaniasis associated hemophagocytic syndrome in patients with chronic granulomatous disease. Pe-diatr Infect Dis J. 2009;28(8):753-4.
6. Finocchi A, Palma P, Di Matteo G, et al. Visceral leishmaniasis revealing chronic granulomatous dis-ease in a child. Int J Immunopathol Pharmacol. 2008;21(3):739-43.
7. Al Ayed MSZ. Visceral Leishmaniasis and Chronic Granulomatous Disease in an Infant. Int J Curr Mi-crobiol App Sci. 2015;4(11):88-91.
8. Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol. 2013;8(3):348-358.
9. Abdolsalehi M, Pourakbari B, Mahmoudi S, Mora-dzadeh M, Keshavarz H, Mamishi S. Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children: A 6-year study from an Iranian referral hospital. Infect Disord Drug Targets. 2020;20(4):461-466.
10. Akhoundi B, Mohebali M, Babakhan L, et al. Rapid detection of human Leishmania infantum infection: A comparative field study using the fast agglutination screening test and the direct agglutination test. Travel Med Infect Dis. 2010;8(5):305-10.
11. Mahmoudvand H, Mohebali M, Sharifi I, et al. Epi-demiological aspects of visceral leishmaniasis in Baft district, Kerman Province, Southeast of Iran. Iran J Parasitol. 2011;6(1):1-11.
12. Mohebali M, Edrisian GH, Nadim A, et al. Appli-cation of direct agglutination test (DAT) for the di-agnosis and seroepidemiological studies of visceral leishmaniasis in Iran. Iran J Parasitol. 2006:1(1):15-25.
13. Meeting WECotCotL, World Health Organization. Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010: World Health Organization; 2010.
14. Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6:147-154.
15. Abdinia B, Oliaei-Motlagh M, Teimouri-Dereshki A. Pediatric visceral leishmaniasis in northwest of Iran. Medicine (Baltimore). 2016;95(44):e526.
16. Kafetzis DA, Maltezou HC. Visceral leishmaniasis in pediatrics. Curr Opin Infect Dis. 2002;15(3):289-94.
17. da Matta VL, Hoshino‐Shimizu S, Dietze R, Cor-bett CE. Detection of specific antibody isotypes and subtypes before and after treatment of Ameri-can visceral leishmaniasis. J Clin Lab Anal. 2000;14(1):5-12.
18. Asensi V, Tricas L, Meana A, et al. Visceral leish-maniasis and other severe infections in an adult pa-tient with p47-phox-deficient chronic granuloma-tous disease. Infection. 2000;28(3):171-4.
IssueVol 16 No 1 (2021) QRcode
SectionCase Report(s)
Chronic granulomatous disease Visceral leishmaniasis Child Iran

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
ABDOLSALEHI MR, MOHEBALI M, KESHAVARZ H, MAHMOUDI S, MAMISHI S. The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report. Iran J Parasitol. 2021;16(1):159-163.